dihydroergotamine has been researched along with Genital Neoplasms, Female in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wille, P | 1 |
| Gorisek, B; Jelatancev, B; Urlep-Salinović, V | 1 |
| Madzhuga, AV; Maslikhova, VN; Pavlova, ZV; Somonova, OV; Zaĭtseva, TI | 1 |
2 trial(s) available for dihydroergotamine and Genital Neoplasms, Female
| Article | Year |
|---|---|
Prevention of postoperative thromboembolism in gynaecological malignancy.
Topics: Adult; Aged; Aged, 80 and over; Dihydroergotamine; Drug Combinations; Female; Genital Neoplasms, Female; Heparin; Humans; Incidence; Middle Aged; Postoperative Complications; Prospective Studies; Risk Factors; Thromboembolism | 1993 |
[Prevention of postoperative thrombotic complications by a combination of small doses of heparin and digitamin in oncologic patients].
Topics: Dihydroergotamine; Drug Combinations; Female; Genital Neoplasms, Female; Heparin; Heparin, Low-Molecular-Weight; Humans; Postoperative Complications; Thrombosis | 1992 |
1 other study(ies) available for dihydroergotamine and Genital Neoplasms, Female
| Article | Year |
|---|---|
[Modern aspects relating to prophylaxis against thrombo-embolism in gynaecology and obstetrics (author's transl)].
Topics: Age Factors; Aspirin; Coumarins; Dextrans; Dihydroergotamine; Dose-Response Relationship, Drug; Female; Genital Neoplasms, Female; Heparin; Humans; Hysterectomy; Risk; Sex Factors; Thromboembolism | 1981 |